MSME (Udyam registered) Ministry of MSME
- Category
- Small (2021-22)
- Udyam number
- UDYAM-TS-20-0030923
Alfansa Bio Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.34 Cr
▼ 28% YoY
Net profit · FY 2025
₹3.99 Lakh
Net margin 3%
EBITDA · FY 2025
₹7.39 Lakh
EBITDA margin 5.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹35 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About Alfansa Bio Private Limited
Data last updated:
Alfansa Bio Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC117252. Its GSTIN is 36AAPCA6036L1Z9 (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Veeraiah Yellavula and Yellavula Sreevani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5 – 5 – 35/23 2nd Floor Murthy Building Prasanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.34 Cr, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹3.99 Lakh (net margin 3%) and EBITDA of ₹7.39 Lakh (EBITDA margin 5.5%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹35 Lakh on record.
Alfansa Bio Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0030923). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website phelixhealthcare.com.
Company details
CIN U74999TG2017PTC117252
Registration Number 117252
Incorporation Date 22 May 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0030923
Recognitions & Rankings of Alfansa Bio
Contact details
Alfansa Bio Private Limited's registered office is in Hyderabad, Telangana. Its website is phelixhealthcare.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address5 – 5 – 35/23 2nd Floor Murthy Building Prasanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alfansa Bio Private Limited, buy the company report.
Comprehensive company report
Alfansa Bio Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Alfansa Bio is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Alfansa Bio Private Limited, buy the company report.
Financials of Alfansa Bio Private Limited
FY 2025 filings availableAlfansa Bio Private Limited reported revenue of ₹1.34 Cr (down 28% YoY) for FY 2025.
Revenue · FY 2025
₹1.34 Cr ▼ 28%
Net profit · FY 2025
₹3.99 Lakh margin 3%
EBITDA · FY 2025
₹7.39 Lakh margin 5.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 28%
3 years · compounded
▼ 18%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 4%
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 28% fall in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alfansa Bio Private Limited, buy the company report.
Board of directors of Alfansa Bio Private Limited
Alfansa Bio has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veeraiah Yellavula | Director | 22 May 2017 | 9 Years 5 Months | Current |
| Yellavula Sreevani | Director | 22 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Alfansa Bio Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Riocure Pharmaceuticals Private Limited | ₹1.34 Cr (FY 2024) | 2.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Speciochem Products Private Limited | ₹1.34 Cr (FY 2025) | -41.0% | Mumbai, Maharashtra, India | |||
| Preferntial Chemicals Private Limited | ₹1.34 Cr (FY 2025) | -11.0% | Vadodara, Gujarat, India | |||
| Raasa Ayurveda Private Limited | ₹1.34 Cr (FY 2025) | 12.0% | Uttar Pradesh, India | |||
| Cluemantra Exim Private Limited | ₹1.34 Cr (FY 2024) | -33.0% | New Delhi, Delhi, India | |||
| Alfansa Bio Private Limitedthis company | ₹1.34 Cr (FY 2025) | ₹3.99 Lakh | 3% | -28.0% | Hyderabad, Telangana, India | |
| Sachin Speciality Chemicals Private Limited C N | ₹1.34 Cr (FY 2024) | 22.0% | Badlapur, Maharashtra, India | |||
| Pothigai Pharma Private Limited | ₹1.34 Cr (FY 2024) | -5.0% | Chennai, Tamil Nadu, India | |||
| Symlek Healthcare Private Limited | ₹1.34 Cr (FY 2024) | 169.0% | Mohali, Punjab, India | |||
| Mitasa Chemicals Pvt Ltd | ₹1.34 Cr (FY 2025) | 7.0% | Siliguri, West Bengal, India | |||
| Medigrand Pharmaceuticals Private Limited | ₹1.34 Cr (FY 2022) | 43.0% | Harur, Tamil Nadu, India |
To see the full peer comparison of Alfansa Bio Private Limited, buy the company report.
Auditor
Alfansa Bio Private Limited is audited by PADARTHI & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PADARTHI & ASSOCIATES | FY 2019 | 010574S |
Shareholding
The shareholding of Alfansa Bio Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Alfansa Bio Private Limited, buy the company report.
Charges & borrowings
Open charges
₹35 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jun 2022 | 100873713 | Hdfc Bank Limited | ₹35 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Alfansa Bio Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alfansa Bio Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alfansa Bio has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAPCA6036L1Z9 | Telangana | Active | 17 Oct 2017 |
To see the full GST registrations and return filing status of Alfansa Bio Private Limited, buy the company report.
Recent activity
Alfansa Bio Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Veeraiah Yellavula was appointed as Director on 22 May 2017.
AGM
Alfansa Bio Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Alfansa Bio Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 35.00 Lakh with Charge ID 100873713 was registered on 03 Jun 2022.
Appointed
Veeraiah Yellavula was appointed as Director.
Appointed
Yellavula Sreevani was appointed as Director.
Incorporation
22 May 2017
Alfansa Bio Private Limited was registered on 22 May 2017 with Roc Hyderabad & aged 9 years 5 months as per MCA records.
Frequently asked questions
Alfansa Bio is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 May 2017 (9+ years old) and is registered under CIN U74999TG2017PTC117252.
Alfansa Bio has 2 current directors:
- Veeraiah Yellavula - Director
- Yellavula Sreevani - Director
The latest financial statements of Alfansa Bio on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Alfansa Bio is 36AAPCA6036L1Z9, registered in Telangana.
The CIN (Corporate Identification Number) of Alfansa Bio is U74999TG2017PTC117252. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alfansa Bio was incorporated on 22 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Alfansa Bio by revenue are Riocure Pharmaceuticals Private Limited, Speciochem Products Private Limited, Preferntial Chemicals Private Limited, Raasa Ayurveda Private Limited, Cluemantra Exim Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Veeraiah Yellavula was appointed as Director on 22 May 2017. Yellavula Sreevani was appointed as Director on 22 May 2017.
Yes, Alfansa Bio is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0030923).
Alfansa Bio can be reached through the website phelixhealthcare.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Alfansa Bio is at 5 – 5 – 3523 2nd Floor Murthy Building Prasanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages